The development of an oral GLP-1 receptor agonist for the management of type 2 diabetes: evidence to date by Antza C, Nirantharakumar K, Doundoulakis I, Tahrani AA, Toulis KA

Get full text

Deep learning predicts heart failure with preserved, mid-range, and reduced left ventricular ejection fraction from patient clinical profiles by Alkhodari, M, Jelinek, HF, Karlas, A, Soulaidopoulos, S, Arsenos, P, Doundoulakis, I, Gatzoulis, KA, Tsioufis, K, Hadjileontiadis, LJ, Khandoker, AH